首页> 外文期刊>Pediatric Pulmonology >Assessing asthma control: Symptom scores, GINA levels of asthma control, lung function, and exhaled nitric oxide
【24h】

Assessing asthma control: Symptom scores, GINA levels of asthma control, lung function, and exhaled nitric oxide

机译:评估哮喘控制:症状评分,哮喘控制的GINA水平,肺功能和呼出气一氧化氮

获取原文
获取原文并翻译 | 示例
           

摘要

Background The childhood asthma control test (C-ACT) is a validated symptom score for assessing asthma control in children. We used a slightly modified version (C-ACT M) of the German C-ACT and compared our results with the literature, correlated the children's part of C-ACT (C-ACT children) with a visual analogue scale (VAS children), explored the agreement between C-ACT M and GINA levels of asthma control, as well as the relationship between C-ACT M and lung function and exhaled nitric oxide (FeNO). Methods We investigated 107 children with a diagnosis of asthma. The study protocol consisted of a clinical examination, assessment of asthma control according to GINA guidelines, administration of C-ACT M, VAS children, lung function, and FeNO. Results Of our patients 66% had, according to GINA, partly controlled-/uncontrolled asthma, 18% were uncontrolled according to C-ACT M. Children with partly controlled-/uncontrolled asthma according to GINA had lower C-ACT M scores than did children with controlled asthma (16.1±3.6SD vs. 25.4±1.8 SD; P0.000), and children with a C-ACT M score ≤ 19 had poorer lung function (mean FEV1% predicted 81.5 ± 13.5 SD vs. 94.2±12.1 SD; P=0.002). Spearman's rank correlation coefficients revealed significant correlations between all symptom scores. Multiple linear regression adjusted for age, gender, FEV1 and FeNO demonstrated a significant relationship between C-ACT M, VAS children, and FEV1 (P=0.003, resp. 0.000), but no significant correlation between C-ACT M, VAS children, and FeNO. Conclusions The German version of C-ACT M is valid and useful for monitoring children with asthma along with tests aimed to follow up lung function and airway inflammation. Concordance between C-ACT M and GINA is moderate, because asthma control assessed by C-ACT M allows more symptoms and lung function is not included in the scoring.
机译:背景技术儿童哮喘控制测试(C-ACT)是用于评估儿童哮喘控制的有效症状评分。我们使用了德国C-ACT的稍加修改版本(C-ACT M),并将我们的结果与文献进行了比较,将C-ACT的儿童部分(C-ACT的儿童)与视觉模拟量表(VAS的儿童)相关联,探索了C-ACT M与GINA控制哮喘水平之间的一致性,以及C-ACT M与肺功能和呼出气一氧化氮(FeNO)的关系。方法我们调查了107名诊断为哮喘的儿童。研究方案包括临床检查,根据GINA指南评估哮喘控制,给予C-ACT M,VAS儿童,肺功能和FeNO。结果根据GINA,在我们的患者中,有66%患有部分控制/不受控制的哮喘,根据C-ACT M,有18%没有控制。根据GINA,患有部分控制/不受控制的哮喘的儿童,C-ACT M得分低于控制性哮喘患儿(16.1±3.6SD vs. 25.4±1.8 SD; P <0.000),以及C-ACT M评分≤19的儿童肺功能较差(平均FEV1%预测为81.5±13.5 SD与94.2±12.1 SD; P = 0.002)。 Spearman的等级相关系数揭示了所有症状评分之间的显着相关性。校正了年龄,性别,FEV1和FeNO的多元线性回归表明,C-ACT M,VAS儿童和FEV1之间存在显着相关性(P = 0.003,分别<0.000),但C-ACT M,VAS儿童之间无显着相关性和FeNO。结论德文版的C-ACT M对监测儿童哮喘以及随访肺功能和气道炎症的检测是有效和有用的。 C-ACT M与GINA的一致性是中等的,因为通过C-ACT M评估的哮喘控制允许更多症状,并且肺功能不包括在评分中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号